A strategy for dual inhibition of the proteasome and fatty acid synthase with belactosin C-orlistat hybrids.
about
Does the enterolactone (ENL) affect fatty acid transporters and lipid metabolism in liver?ω-3 Long Chain Polyunsaturated Fatty Acids as Sensitizing Agents and Multidrug Resistance Revertants in Cancer Therapy.Quantitative chemoproteomic profiling reveals multiple target interactions of spongiolactone derivatives in leukemia cells.
P2860
A strategy for dual inhibition of the proteasome and fatty acid synthase with belactosin C-orlistat hybrids.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
A strategy for dual inhibition ...... belactosin C-orlistat hybrids.
@ast
A strategy for dual inhibition ...... belactosin C-orlistat hybrids.
@en
type
label
A strategy for dual inhibition ...... belactosin C-orlistat hybrids.
@ast
A strategy for dual inhibition ...... belactosin C-orlistat hybrids.
@en
prefLabel
A strategy for dual inhibition ...... belactosin C-orlistat hybrids.
@ast
A strategy for dual inhibition ...... belactosin C-orlistat hybrids.
@en
P2093
P2860
P1476
A strategy for dual inhibition ...... belactosin C-orlistat hybrids.
@en
P2093
Andres Garcia
Bianca Ramirez
Caitlen B Walker
Christopher T Wilson
James C Sacchettini
James T Moore
Jeffrey W Smith
Joanna Krysiak
Ju Anne Yau
Kenneth G Hull
P2860
P304
P356
10.1016/J.BMC.2017.01.020
P407
P50
P577
2017-01-19T00:00:00Z